What is it about?

We report on early-stage results of feasibility and accuracy of real-time continuous glucose monitoring in the intensive care unit setting during the COVID-19 pandemic. We found CGM to be considerably accurate, safe, and meaningfully reduced the need for POC testing.

Featured Image

Read the Original

This page is a summary of: Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic, Diabetes Care, December 2020, American Diabetes Association,
DOI: 10.2337/dc20-2219.
You can read the full text:

Read

Contributors

The following have contributed to this page